CEACAM5 and colorectal cancer: A genome-wide scale study with plasma and serum samples from 107 colorectal cancer patients and 98 individuals without colorectal cancer revealed that analysis of methylated THBD and C9orf50 outperformed carcinoembryonic antigen (CEA) measurement for early colorectal cancer detection [48].